Showing results (401-410 of 431) with videos related to
Sort By:
Pageof 44
Journal of the National Cancer Institute|November 7, 2019
Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307Julie R Gralow, William E Barlow, Alexander H G Paterson, et al.Pharmacogenetics and Genomics|December 27, 2017
Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated lociLara E Sucheston-Campbell, Alyssa I Clay-Gilmour, William E Barlow, et al.Clinical Chemistry|December 2, 2008
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancersCatharine M Sturgeon, Michael J Duffy, Ulf-Håkan Stenman, et al.JCO Precision Oncology|November 29, 2022
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker SummitDaniel F Hayes, Roy S Herbst, Jonathan L Myles, et al.Nature Communications|September 27, 2016
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progressionYashar S Niknafs, Sumin Han, Teng Ma, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer PatientsDavid Chu, Costanza Paoletti, Christina Gersch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast CancerCynthia X Ma, Ron Bose, Feng Gao, et al.Cancer Research|December 14, 2017
Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance MechanismsCostanza Paoletti, Andi K Cani, Jose M Larios, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 26, 2018
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancerDavid L Rimm, Samuel C Y Leung, Lisa M McShane, et al.Molecular Oncology|December 6, 2021
Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detectionAndi K Cani, Emily M Dolce, Elizabeth P Darga, et al.Pageof 44